The Shifting Sands of Sentiment: Zacks Re-evaluates On Holding, Marking a New Chapter
A Fresh Look at the Parks: Mizuho Sees More Upside for United Parks & Resorts
The Shifting Sands of Wall Street: What Evercore ISI's PPG Reassessment Means
The Crystal Ball of Wall Street: Why One Firm Sees LightPath Technologies Soaring
The Shifting Sands of Ad Tech: Barclays Takes a Closer Look at DoubleVerify's Horizon
The Great Rebound? Why One Major Analyst Is Eyeing Expedia's Soaring Potential
Biotech Buzz: Leerink Partners Bets Big on Monopar's Future
A Second Look: Wall Street's Shifting Stance on Coherus BioSciences
The Shifting Sands Beneath Life360: A Wall Street Zen Reassessment
The Shifting Sands: JPMorgan Chimes In on Treace Medical, and It's a Sobering Note
Amidst Market Churn: The Enduring Stability of Cold Storage and Americold's Steady Outlook
Wall Street's Eye on Procore: Is $91 the New Horizon for the Construction Tech Giant?
AMD's Moment in the Sun? Why Analysts Are Looking Up at the Chip Giant
The Luxury Beat: Why Wall Street Is Betting Big on Tapestry's Future
The Great Rebound: Why Wall Street's Whispers Point to Expedia's Ascent
The Shifting Tides: Why Zacks Just Tapped the Brakes on NAPCO Security's Stock
The Construction Cloud Just Got a Vote of Confidence: Why Procore's Future Might Be Building Up
The Future Looks Brighter: Ouster Scores a Major Vote of Confidence from Wall Street
The Ascent of V2X: Analysts Eye a Brighter Horizon for the Defense Contractor
Market Watch: Goldman Sachs Takes a Fresh Look at Gartner’s Horizon
Nektar Therapeutics: A Whisper of Change on Wall Street?
A Fresh Look at Integra LifeSciences: Why Wall Street Zen Just Called it a 'Strong Buy'
A Whisper of Change: Decoding Wall Street's Latest Take on OFS Capital
The Shifting Sands of Biotech: Wall Street Zen Taps Puma Biotech's Roar Down a Notch
A Second Look? Wall Street Zen Shifts Stance on ECARX, Moving to a 'Hold'
A Shift in the Tides: Wall Street Zen Takes a More Measured View of American Coastal Insurance
A Whisper of Optimism? Envoy Medical Catches a Glimmer of Hope on Wall Street.
The Shifting Sands: Wall Street Zen's Stark Warning for CLIMB Bio
The Biotech Horizon: Why Immunome Continues to Catch the Eye of Wall Street
Fortinet's Financial Pulse: Decoding Wall Street's Latest Bullish Bet
The Sonos Sound: Why One Analyst Hears a Symphony of Growth
The Silent Giant: Why Wall Street Thinks SkyWater Technology Is Ready to Soar
The Steady Hand: Why Fiserv's 'Neutral' Rating Isn't Budging
Spotify's Soaring Ambitions: Why Analysts See a Sky-High Future for the Audio Giant
Cirrus Logic's Big Leap: Why Benchmark Just Set a Bold New Price Target
Uber's Momentum Check: Wall Street Weighs In, Targets Adjust
The Unexpected Sizzle: Why El Pollo Loco Just Earned a "Strong Buy" Rating
The Shifting Tides: Why Metalla Royalty & Streaming Just Caught the Eye of Capital Markets
The Shifting Tides of Retail: JPMorgan's Latest Take on Newell Brands
The AI Gold Rush: Why Wall Street Sees NVIDIA's Star Soaring Even Higher
NVIDIA's Relentless Ascent: Loop Capital's Bullish New Stance on the Green Machine
A Slight Tweak, But What Does it Mean? AXIS Capital's Outlook Gets a Haircut From KBW
The Vertex Verdict: One Analyst's Shifting Outlook on NASDAQ:VERX